All About SGLT Inhibitors for T1D

SGLT inhibitors are oral medications that work by decreasing the production of transport proteins and reducing the absorption of glucose by the intestines and kidneys respectively. Up until now, these drugs have been used exclusively by those with Type 2 diabetes. Inhibitors on the market currently include SGLT-2 inhibitors Farxiga and Jardiance, and Zynquista, the first dual SGLT-1 and SGLT-2 inhibitor.

Colorado Becomes First State to Pass Bill Capping Insulin Costs

On Wednesday, May 22, Colorado became the first state in the U.S. to put a price cap on insulin.

FDA Approves New Treatment for Diabetic Retinopathy

Regeneron Pharmaceuticals announced that the FDA has approved EYLEA (aflibercept) to treat all stages of diabetic retinopathy.

Express Scripts Won’t Cover Lilly’s Generic Insulin

The largest PBM in the U.S. recently released a list of formulary exclusions that included 'Insulin Lispro' as an excluded medication.

Previously Healthy from Beyond Type 1 Named Webby People’s Voice Award Winner

Hailed as the “Internet’s highest honor” and “the Oscars of the Internet” The Webby Awards are presented by the International Academy of Digital Arts and Sciences (IADAS) honoring excellence on the Internet.

DIY Loop Now Compatible with Omnipod

Loop announced that a testing branch of their DIY Loop is now compatible with the current 'Eros' generation of Omnipod, and available to the public.

Woman’s Insulin Confiscated By Airport Security

A woman boarding a flight in the UK had her insulin taken from her by airport security and subsequently boarded her flight without it.

Insulin Manufacturers and PBMs Testify Before Congress

The hearing was contentious throughout, with House members grilling both the manufacturers and the PBM representatives about the reasons for high costs.

Cigna Plan Could Cap Insulin Costs at $25 a Month

Cigna and Express Scripts announced on Wednesday that they would be lowering the out-of-pocket cost of insulin for some patients with diabetes.

Senseonics Appoints Francine R. Kaufman, M.D. as Chief Medical Officer

Francine R. Kaufman, M.D., a member of Beyond Type 1’s Science Advisory Council, was appointed Chief Medical Officer at Senseonics.

First Oral Medication to Treat T1D Approved in Europe

The European Commission (EC) has approved the use of Forxiga (dapagliflozin) as an add-on treatment to insulin therapy for use in in patients with T1D who have a BMI ≥ 27 kg/m2

European Commission Approves Zynquista, First Dual SGLT Inhibitor for T1D

Zynquista is the first dual SGLT1 and SGLT2 inhibitor approved for use in Type 1 diabetes, and the second oral medication approved for use in Type 1 diabetes. 

FDA Declines to Approve First Oral Medication for Type 1 Diabetes

The FDA issued a Complete Response Letter for the SGLT-1/2 inhibitor Zynquista (sotagliflozin), declining to approve it for use in T1D at this time.

Making An Invisible Disease Visible: Injecting Myself On Adventure Cyclist Magazine

Annalisa van den Bergh injects herself on the cover of Adventure Cycling, the largest cycling magazine.

Insulin Manufacturers Called on to Explain Skyrocketing Prices

On Tuesday, a group of U.S. Senators led by Patty Murray (D-WA) sent letters to executives at Eli Lilly, Novo Nordisk, and Sanofi demanding information about the rising prices of insulin.